Luxin Sun

7PUBLICATIONS
44CO-AUTHORS
Wastewater treatment processesProteins and peptidesCheminformatics and quantitative structure-activity relationshipsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 23, 2026
Discovery and Optimization of Isoform Selective ULK1 Degraders to Enhance Antitumor Activity in KRAS-Mutant Cancer.

|Jul 23, 2026
Late-stage functionalization with strain-release warheads enables tunable covalent inhibition.

|Jan 14, 2026
Structure-Activity and Structure-Degradation Relationship Studies of 2-Amino-6-(benzimidazol-2-ylmethyl)-N9-heteroarylpurines as Potent and Selective CDK12/13 Inhibitors and Cyclin K Degraders.

Thiyagamurthy Pandurangan, Solomon Tadesse Zeleke, Anna Iermolaieva

|Oct 25, 2024
Discovery and design of molecular glue enhancers of CDK12-DDB1 interactions for targeted degradation of cyclin K.

Pompom Ghosh, Maximilian Schmitz, Thiyagamurthy Pandurangan

|Jun 03, 2023
Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding.

Erik B Faber, Luxin Sun, Jian Tang

|Jan 26, 2023
Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in Mice.

Erik B Faber, Nan Wang, Kristen John

Pageof 2

Frequent Collaborators

7 joint publications

Ernst Schönbrunn

5 joint publications

Andrii Monastyrskyi

4 joint publications

Dylan Grassie

2 joint publications

Gunda I Georg